HT
IBIO icon

Headlands Technologies’s iBio IBIO Stock Holding History

Headlands Technologies’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83K Buy
47,413
+36,463
+333% +$65.2K 0.01% 667
2026
Q1 		$20.8K Buy
+10,950
New +$25.4K ﹤0.01% 711

Other funds holding IBIO

AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Headlands Technologies's IBIO Position: Q2 2026 in Review

Headlands Technologies increased its iBio (IBIO) stake by 333% in Q2 2026, buying an estimated $65.2K and bringing the position to 47,413 shares worth $83K. The position accounts for 0.01% of the portfolio, ranked #667.

Headlands Technologies first reported a position in IBIO in Q1 2026 and has held it in 2 quarters since. 55 funds tracked by Wall St. Rank hold IBIO as of Q2 2026.

  • Headlands Technologies held 47,413 shares of iBio worth $83K as of Q2 2026.
  • Headlands Technologies bought 36,463 iBio shares in Q2 2026, an estimated $65.2K.
  • iBio made up 0.01% of Headlands Technologies's portfolio in Q2 2026, its #667 holding.
  • Headlands Technologies first reported a position in iBio in Q1 2026 and has held it in 2 quarters since.
  • 55 funds tracked by Wall St. Rank held iBio as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.